你即將離開本站

並前往https://docs.publicnow.com/65B5D99F23A29D1958918B43D08168A72E77EFDE

Orphazyme provides update for planned NDA resubmission ...

CO; ORPH) (“Orphazyme” or the “Company”), a late-stage biopharmaceutical company ... to align on a path to resubmission for arimoclomol in NPC with the FDA.

確定！ 回上一頁

查詢 「ORPH FDA」的人也找了：

  1. ORPH FDA approval
    2.
  2. Orphazyme A/S news
    3.
  3. Orphazyme
    4.
  4. FDA IND database
    5.
  5. Orphan drug Act
    6.
  6. ORPH stock
    7.
  7. Orphan FDA
    8.
  8. Orphazyme as adr
    9.